AAAAAA

   
Results: 1-25 |
Results: 25
Adaptation and validation of the rheumatoid arthritis quality of life scale for use in Canada
Authors: Neville, C Whalley, D McKenna, S Le Comte, M Fortin, PR
Citation: C. Neville et al., Adaptation and validation of the rheumatoid arthritis quality of life scale for use in Canada, J RHEUMATOL, 28(7), 2001, pp. 1505-1510
The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus
Authors: Wang, CC Mayo, NE Fortin, PR
Citation: Cc. Wang et al., The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus, J RHEUMATOL, 28(3), 2001, pp. 525-532
Living with lupus: A prospective Pan-Canadian study
Authors: Dobkin, PL Da Costa, D Fortin, PR Edworthy, S Barr, S Esdaile, JM Senecal, JL Goulet, JR Choquette, D Rich, E Beaulieu, A Cividino, A Ensworth, S Smith, D Zummer, M Gladman, D Clarke, AE
Citation: Pl. Dobkin et al., Living with lupus: A prospective Pan-Canadian study, J RHEUMATOL, 28(11), 2001, pp. 2442-2448
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus
Authors: Esdaile, JM Abrahamowicz, M Grodzicky, T Li, Y Panaritis, C du Berger, R Cote, R Grover, SA Fortin, PR Clarke, AE Senecal, JL
Citation: Jm. Esdaile et al., Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus, ARTH RHEUM, 44(10), 2001, pp. 2331-2337
Do lupus disease activity measures detect clinically important change?
Authors: Fortin, PR Abrahamowicz, M Clarke, AE Neville, C Du Berger, R Fraenkel, L Liang, MIH
Citation: Pr. Fortin et al., Do lupus disease activity measures detect clinically important change?, J RHEUMATOL, 27(6), 2000, pp. 1421-1428
Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity
Authors: Neville, C Clarke, AE Joseph, L Belisle, P Ferland, D Fortin, PR
Citation: C. Neville et al., Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity, J RHEUMATOL, 27(3), 2000, pp. 675-679
A subset of rheumatoid factors crossreacts with cardiolipin in patients positive for IgM rheumatoid factor and anticardiolipin antibodies
Authors: Galperin, I Fortin, PR Subang, R Newkirk, MM Rauch, J
Citation: I. Galperin et al., A subset of rheumatoid factors crossreacts with cardiolipin in patients positive for IgM rheumatoid factor and anticardiolipin antibodies, J RHEUMATOL, 27(3), 2000, pp. 820-821
Association between IgM response to IgG damaged by glyoxidation and disease activity in rheumatoid arthritis
Authors: Lucey, MD Newkirk, MM Neville, C Lepage, K Fortin, PR
Citation: Md. Lucey et al., Association between IgM response to IgG damaged by glyoxidation and disease activity in rheumatoid arthritis, J RHEUMATOL, 27(2), 2000, pp. 319-323
Determinants of health status in fibromyalgia: A comparative study with systemic lupus erythematosus
Authors: Da Costa, D Dobkin, PL Fitzcharles, MA Fortin, PR Beaulieu, A Zummer, M Senecal, JL Goulet, JR Rich, E Choquette, D Clarke, AE
Citation: D. Da Costa et al., Determinants of health status in fibromyalgia: A comparative study with systemic lupus erythematosus, J RHEUMATOL, 27(2), 2000, pp. 365-372
Underestimating the value of women: Assessing the indirect costs of women with systemic lupus erythematosus
Authors: Clarke, AE Penrod, J St Pierre, Y Petri, MA Manzi, S Isenberg, DA Gordon, C Senecal, JL Fortin, PR Sutcliffe, N Goulet, JR Choquette, D Grodzicky, T Esdaile, JM
Citation: Ae. Clarke et al., Underestimating the value of women: Assessing the indirect costs of women with systemic lupus erythematosus, J RHEUMATOL, 27(11), 2000, pp. 2597-2604
The use of alternative medical therapies in patients with systemic lupus erythematosus
Authors: Moore, AD Petri, MA Manzi, S Isenberg, DA Gordon, C Senecal, JL St Pierre, Y Joseph, L Penrod, J Fortin, PR Sutcliffe, N Goulet, JR Choquette, D Grodzicky, T Esdaile, JM Clarke, AE
Citation: Ad. Moore et al., The use of alternative medical therapies in patients with systemic lupus erythematosus, ARTH RHEUM, 43(6), 2000, pp. 1410-1418
The relationship between health status, social support and satisfaction with medical care among patients with systemic lupus erythematosus
Authors: Da Costa, D Clarke, AE Dobkin, PL Senecal, JL Fortin, PR Danoff, DS Esdaile, JM
Citation: D. Da Costa et al., The relationship between health status, social support and satisfaction with medical care among patients with systemic lupus erythematosus, INT J QUAL, 11(3), 1999, pp. 201-207
Recruitment strategies in superiority trials in SLE: lessons from the study of methotrexate in lupus erythematosus (SMILE)
Authors: Ferland, D Fortin, PR
Citation: D. Ferland et Pr. Fortin, Recruitment strategies in superiority trials in SLE: lessons from the study of methotrexate in lupus erythematosus (SMILE), LUPUS, 8(8), 1999, pp. 606-611
Discordance between patients and their physicians in the assessment of lupus disease activity: relevance for clinical trials
Authors: Yen, JC Neville, C Fortin, PR
Citation: Jc. Yen et al., Discordance between patients and their physicians in the assessment of lupus disease activity: relevance for clinical trials, LUPUS, 8(8), 1999, pp. 660-670
Quality of life in systemic lupus erythematosus patients during more and less active disease states: Differential contributors to mental and physicalhealth
Authors: Dobkin, PL Da Costa, D Dritsa, M Fortin, PR Senecal, JL Goulet, JR Choquette, D Rich, E Beaulieu, A Cividino, A Edworthy, S Barr, S Ensworth, S Esdaile, JM Gladman, D Smith, D Zummer, M Clarke, AE
Citation: Pl. Dobkin et al., Quality of life in systemic lupus erythematosus patients during more and less active disease states: Differential contributors to mental and physicalhealth, ARTH C RES, 12(6), 1999, pp. 401-410
The needs of patients with arthritis: The patient's perspective
Authors: Neville, C Fortin, PR Fitzcharles, MA Baron, M Abrahamowitz, M Du Berger, R Esdaile, JM
Citation: C. Neville et al., The needs of patients with arthritis: The patient's perspective, ARTH C RES, 12(2), 1999, pp. 85-95
The role of stress in functional disability among women with systemic lupus erythematosus: A prospective study
Authors: Da Costa, D Dobkin, PL Pinard, L Fortin, PR Danoff, DS Esdaile, JM Clarke, AE
Citation: D. Da Costa et al., The role of stress in functional disability among women with systemic lupus erythematosus: A prospective study, ARTH C RES, 12(2), 1999, pp. 112-119
An international perspective on the well being and health care costs for patients with systemic lupus erythematosus
Authors: Clarke, AE Petri, MA Manzi, S Isenberg, DA Gordon, C Senecal, JL St Pierre, Y Joseph, L Penrod, J Fortin, PR Sutcliffe, N Goulet, JR Choquette, D Grodzicky, T Danoff, DS Ho, V Esdaile, JM
Citation: Ae. Clarke et al., An international perspective on the well being and health care costs for patients with systemic lupus erythematosus, J RHEUMATOL, 26(7), 1999, pp. 1500-1511
Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices
Authors: Moore, AD Clarke, AE Danoff, DS Joseph, L Belisle, P Neville, C Fortin, PR
Citation: Ad. Moore et al., Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices, J RHEUMATOL, 26(6), 1999, pp. 1285-1290
Discontinuation of antimalarial drugs in systemic lupus erythematosus
Authors: Wang, CC Fortin, PR Li, Y Panaritis, T Gans, M Esdaile, JM
Citation: Cc. Wang et al., Discontinuation of antimalarial drugs in systemic lupus erythematosus, J RHEUMATOL, 26(4), 1999, pp. 808-815
Systemic lupus erythematosus, a disease associated with low levels of clusterin/ApoJ, an antiinflammatory protein
Authors: Newkirk, MM Apostolakos, P Neville, C Fortin, PR
Citation: Mm. Newkirk et al., Systemic lupus erythematosus, a disease associated with low levels of clusterin/ApoJ, an antiinflammatory protein, J RHEUMATOL, 26(3), 1999, pp. 597-603
Outcomes of total hip and knee replacement - Preoperative functional status predicts outcomes at six months after surgery
Authors: Fortin, PR Clarke, AE Joseph, L Liang, MH Tanzer, M Ferland, D Phillips, C Partridge, AJ Belisle, P Fossel, AH Mahomed, N Sledge, CB Katz, JN
Citation: Pr. Fortin et al., Outcomes of total hip and knee replacement - Preoperative functional status predicts outcomes at six months after surgery, ARTH RHEUM, 42(8), 1999, pp. 1722-1728
The American College of Rheumatology Nomenclature and Case Definitions forNeuropsychiatric Lupus Syndromes
Authors: Liang, MH Corzillius, M Bae, SC Lew, RA Fortin, PR Gordon, C Isenberg, D Alarcon, GS Straaton, KV Denburg, S Esdaile, JM Glanz, BI Karlson, EW Khoshbin, S Rogers, MP Schur, PH Hanly, JG Kozora, E West, S Lahita, RG Lockshin, MD McCune, J Moore, PM Petri, M Roberts, WN Sanchez-Guerrero, J Veilleux, M Brey, R Cornblath, WD Filley, CM Fisk, JD Harten, P Hay, EM Iverson, G Levine, SR Waterhouse, E Wallace, DJ Winer, JB
Citation: Mh. Liang et al., The American College of Rheumatology Nomenclature and Case Definitions forNeuropsychiatric Lupus Syndromes, ARTH RHEUM, 42(4), 1999, pp. 599-608
Inhibition of lupus anticoagulant activity by hexagonal phase phosphatidylethanolamine in the presence of prothrombin
Authors: Rauch, J Tannenbaum, M Neville, C Fortin, PR
Citation: J. Rauch et al., Inhibition of lupus anticoagulant activity by hexagonal phase phosphatidylethanolamine in the presence of prothrombin, THROMB HAEM, 80(6), 1998, pp. 936-941
A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGE
Authors: Ligier, S Fortin, PR Newkirk, MM
Citation: S. Ligier et al., A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGE, BR J RHEUM, 37(12), 1998, pp. 1307-1314
Risultati: 1-25 |